Early Antiretroviral Therapy: An Immunotherapy to Combat HCV in HIV-1/HCV Coinfection

Abstract

Arthur Y Kim Massachusetts General Hospital/Harvard Medical School, Partners AIDS Research Center and Infectious Disease Unit, Boston, MA, USA Tel.: +1 617 726 3812; Fax: +1 617 726 5411; akim1@partners.org ‘...we have reasonable evidence that ART represents a modulation of the immune system with a positive clinical and immunological effect and therefore can be considered an immunotherapy for HCV in HCV/HIV-1 coinfected subjects.’